United States · 
Who invested in Dauntless Pharmaceuticals?
Dauntless Pharmaceuticals's investors include Sofinnova Investments.
2016
$3.0MVenture$12MSeries AUnited States · Series A startup
Who invested in Dauntless Pharmaceuticals
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Dauntless Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$15Mraised across 2 rounds since 2015, from 2 sources
$3.0MVenture$12MSeries A
- Latest round
- Series A, $12MJul 2015
- Step-upi
- 4×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $3.0M Jun 2015
- Biggest round
- $12M Series A · Jul 2015
- Between rounds
- 1 month from the last two
The rounds
- Jul 2015
- Jun 2015Venture$3.0M
No investor was named in the report.
From a historical funding record
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Dauntless Pharmaceuticals
How much has Dauntless Pharmaceuticals raised?
Dauntless Pharmaceuticals has raised $15M across 2 rounds since 2015.
When did Dauntless Pharmaceuticals last raise?
Dauntless Pharmaceuticals's most recent round was a Series A of $12M in Jul 2015.
What was Dauntless Pharmaceuticals's biggest round?
Its most recent round, $12M in Jul 2015, is also its largest on record.
Who backed Dauntless Pharmaceuticals first?
Dauntless Pharmaceuticals's first round on record, in Jul 2015, was backed by Sofinnova Investments.
What stage is Dauntless Pharmaceuticals at?
Dauntless Pharmaceuticals's latest named round is a Series A, in Jul 2015.
Where is Dauntless Pharmaceuticals based?
Dauntless Pharmaceuticals is based in the United States.
Companies like Dauntless Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.